Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Heart Failure with Preserved Ejection Fraction, An Issue of Cardiology Clinics
- 1st Edition, Volume 40-4 - October 13, 2022
- Editors: Scott L. Hummel, Matthew C. Konerman
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 3 9 8 1 - 2
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 3 9 8 2 - 9
In this issue of Cardiology Clinics, guest editors Drs. Scott Hummel and Matthew Konerman bring their considerable expertise to the topic of Heart Failure with Preserved Ejection… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Cardiology Clinics, guest editors Drs. Scott Hummel and Matthew Konerman bring their considerable expertise to the topic of Heart Failure with Preserved Ejection Fraction. Top experts in the field cover key topics such as risk factors for heart failure with preserved ejection fraction (HFpEF); cardiopulmonary stress testing in HFpEF; hemodynamic assessment in HFpEF; the role of multi-modality imaging in the evaluation of HFpEF; and more.
-
Contains 13 relevant, practice-oriented topics including pharmacologic, non-pharmacologic, and device therapy for HFpEF; geriatric domains in patients with HFpEF; pulmonary hypertension in HFpEF; infiltrative, genetic, and other non-standard causes of HFpEF; echocardiography in HFpEF; and more.
-
Provides in-depth clinical reviews on heart failure with preserved ejection fraction, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Cardiology
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction
- Key points
- Epidemiology
- Clinical presentation and diagnostic criteria
- Evaluation for Alternative Diagnoses
- Addressing misconceptions about heart failure with preserved ejection fraction diagnosis
- An overview of heart failure with preserved ejection fraction pathophysiology: four major themes
- Suggested initial diagnostic and therapeutic approach to heart failure with preserved ejection fraction
- Summary
- Clinics care points
- Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies
- Key points
- Introduction
- Summary and future directions
- Clinics care points
- Disclosure
- Approach to Echocardiography in Heart Failure with Preserved Ejection Fraction
- Key points
- Introduction
- Summary
- Clinics care points
- Disclosure
- The Role of Multimodality Imaging in the Evaluation of Heart Failure with Preserved Ejection Fraction
- Key points
- Initial evaluation and establishing the diagnosis of HFpEF
- Identification of specific phenotypes of HFpEF
- Imaging of extracardiac organs in HFpEF
- Summary
- Clinics care points
- Conflict of interest/disclosures
- Hemodynamic Assessment in Heart Failure with Preserved Ejection Fraction
- Key points
- Introduction
- Performing an invasive exercise hemodynamics
- Normal hemodynamic ranges at rest and with exercise
- Interpretation of specific hemodynamic signatures
- Other assessments
- Summary
- Clinics care points
- Sources of Funding
- Disclosures
- Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction
- Key points
- Introduction
- Summary
- Clinics care points
- Disclosure
- Funding statement
- Nonpharmacological Strategies in Heart Failure with Preserved Ejection Fraction
- Key points
- Introduction
- Reduced cardiorespiratory fitness in patients with heart failure with preserved ejection fraction
- Exercise training
- Summary
- Clinics care points
- Disclosures
- Device Therapy for Heart Failure with Preserved Ejection Fraction
- Key points
- Introduction
- Summary
- Clinics care points
- Disclosure
- Financial support
- Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction
- Key points
- Introduction
- Summary
- Disclosures
- Sources of funding
- Clinics care points
- Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
- Key points
- Introduction
- How should pulmonary hypertension-heart failure with preserved ejection fraction be defined?
- Is pulmonary hypertension-heart failure with preserved ejection fraction common?
- What are the clinical implications of pulmonary hypertension in heart failure with preserved ejection fraction?
- How can pulmonary arterial hypertension and pulmonary hypertension-heart failure with preserved ejection fraction be differentiated?
- Are there treatment options for patients with pulmonary hypertension-heart failure with preserved ejection fraction?
- Summary
- Clinics care point
- Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an “Old” Disease
- Key points
- Introduction
- History of cardiac amyloidosis
- Pathophysiology and epidemiology
- Staging of transthyretin-cardiac amyloidosis
- Symptoms and clinical findings
- Clinical findings (biomarkers, echo, magnetic resonance imaging , scintigraphy, biopsy, and genetic testing)
- Therapy
- Summary and conclusion
- Clinics care points
- Disclosure
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 40-4
- Published: October 13, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323939812
- eBook ISBN: 9780323939829
SH
Scott L. Hummel
Affiliations and expertise
Associate Professor, Advanced Heart Failure and Transplant Cardiology, University of MichiganMK
Matthew C. Konerman
Affiliations and expertise
Assistant Professor, Advanced Heart Failure and Transplant Cardiology, University of Michigan